The Role of Endothelial Progenitor Cells in Atherosclerosis and Impact of Anti-Lipemic Treatments on Endothelial Repair

The Role of Endothelial Progenitor Cells in Atherosclerosis and Impact of Anti-Lipemic Treatments on Endothelial Repair

Cardiovascular complications are associated with advanced atherosclerosis. Although atherosclerosis is still regarded as an incurable disease, at least in its more advanced stages, the discovery of endothelial progenitor cells (EPCs), with their ability to replace old and injured cells and different...

Full description

Bibliographic Details
Main Authors:	Velimir Altabas, Lora Stanka Kirigin Biloš
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	International Journal of Molecular Sciences
Subjects:	endothelial progenitor cells statins fibrates PCSK9 inhibitors angiopoietein-like protein inhibitors LDL apheresis
Online Access:	https://www.mdpi.com/1422-0067/23/5/2663

Similar Items

Pharmacological Options in Atherosclerosis: A Review of the Existing Evidence
by: Keshav Kumar Gupta, et al.
Published: (2018-12-01)

Effects of Hypolipidemic Drugs on Psoriasis
by: Mateusz Matwiejuk, et al.
Published: (2023-03-01)

Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs
by: Donatella Zodda, et al.
Published: (2018-01-01)

Low-density lipoprotein cholesterol lowering treatment: the current approach
by: Irina Crismaru, et al.
Published: (2020-05-01)

The Importance of Arterial Stiffness Assessment in Patients with Familial Hypercholesterolemia
by: Beáta Kovács, et al.
Published: (2022-05-01)

Low-density lipoprotein particles in atherosclerosis
by: Ya-Nan Qiao, et al.
Published: (2022-08-01)

The Impact of Modern Anti-Diabetic Treatment on Endothelial Progenitor Cells
by: Velimir Altabas, et al.
Published: (2023-11-01)

Editorial: Genetics of familial hypercholesterolemia: New insight—Volume II
by: Alpo Vuorio, et al.
Published: (2022-10-01)

Editorial: Genetics of Familial Hypercholesterolemia: New Insight
by: Alpo Vuorio, et al.
Published: (2021-05-01)

Long-Term LDL-Apheresis Treatment and Dynamics of Circulating miRNAs in Patients with Severe Familial Hypercholesterolemia
by: Dana Dlouha, et al.
Published: (2023-08-01)

AUTOIMMUNE DISEASES AND ATHEROSCLEROSIS - PROBLEMS OF TREATMENT
by: I. V. Shirinskiy, et al.
Published: (2012-05-01)

HYPOLIPIDEMIC MEDICATIONS: CURRENT USE AND FUTURE PERSPECTIVES. PART 1. NON-STATIN HYPOLIPIDEMIC MEDICATIONS
by: A. E. Bagriy, et al.
Published: (2016-03-01)

Blocking cholesterol formation and turnover improves cellular and mitochondria function in murine heart microvascular endothelial cells and cardiomyocytes
by: Alicja Braczko, et al.
Published: (2023-09-01)

PCSK9 Inhibitor Therapy as an Alternative for Statin Intolerance
by: K. O. Shnaider, et al.
Published: (2023-12-01)

Advances on the treatment of Dyslipidaemias
by: Eleni Bilianou
Published: (2017-01-01)

Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome
by: Gianni Biolo, et al.
Published: (2022-10-01)

Undertreatment or Overtreatment With Statins: Where Are We?
by: Irene García-Fernández-Bravo, et al.
Published: (2022-04-01)

LDL Cholesterol, Statins And PCSK 9 Inhibitors
by: Sanjiv Gupta
Published: (2015-09-01)

PCSK9 Inhibitors Reduce PCSK9 and Early Atherogenic Biomarkers in Stimulated Human Coronary Artery Endothelial Cells
by: Rahayu Zulkapli, et al.
Published: (2023-03-01)

Combined statin-fibrate therapy-induced rhabdomyolysis: Case report
by: Jozić Tanja L., et al.
Published: (2014-01-01)

Circulating Endothelial Cells, Endothelial Progenitor Cells, and Endothelial Microparticles in Cancer
by: P.K.Y. Goon, et al.
Published: (2006-02-01)

Effects of ACE inhibition on endothelial progenitor cell mobilization and prognosis after acute myocardial infarction in type 2 diabetic patients
by: Jia-Yin Sun, et al.
Published: (2013-05-01)

Supplementation with Octacosanol Affects the Level of PCSK9 and Restore Its Physiologic Relation with LDL-C in Patients on Chronic Statin Therapy
by: Milica Zrnic Ciric, et al.
Published: (2021-03-01)

Role of Endothelial Progenitor Cells in Frailty
by: Klara Komici, et al.
Published: (2023-01-01)

Role of PCSK9 inhibitors in the management of dyslipidaemia
by: Tiny Nair
Published: (2024-03-01)

Is lower better? Is lowest the best?
by: Lale Tokgözoğlu
Published: (2017-04-01)

Endothelial Transcytosis of Lipoproteins in Atherosclerosis
by: Xinbo Zhang, et al.
Published: (2018-09-01)

Long-Term Cardiovascular and Cerebrovascular Challenges Posed by COVID-19 in Patients With Familial Hypercholesterolemia
by: Alpo Vuorio, et al.
Published: (2022-05-01)

Medical Management of Dyslipidemia for Secondary Stroke Prevention: Narrative Review
by: Yoonkyung Chang, et al.
Published: (2023-04-01)

Blood lipid levels and treatment following an acute coronary syndrome or coronary intervention – Journey from hospital to cardiac rehabilitation
by: David Rott, et al.
Published: (2022-12-01)

Endothelial Progenitor Cell Levels and Extent of Post-prandial Lipemic Response
by: Buket Akcan, et al.
Published: (2022-02-01)

The Role of Endothelial Progenitors in the Repair of Vascular Damage in Systemic Sclerosis
by: Nicoletta Del Papa, et al.
Published: (2018-06-01)

Erythropoietin Stimulates Endothelial Progenitor Cells to Induce Endothelialization in an Aneurysm Neck After Coil Embolization by Modulating Vascular Endothelial Growth Factor
by: Peixi Liu, et al.
Published: (2016-09-01)

Current Role of Lipoprotein Apheresis in the Treatment of High-Risk Patients
by: Ulrich Julius
Published: (2018-05-01)

Geranylgeranyl isoprenoids and hepatic Rap1a regulate basal and statin-induced expression of PCSK9
by: Yating Wang, et al.
Published: (2024-03-01)

An Analysis of the Gut Microbiota and Related Metabolites following PCSK9 Inhibition in Statin-Treated Patients with Elevated Levels of Lipoprotein(a)
by: Jose A. Caparrós-Martín, et al.
Published: (2024-01-01)

Lipid lowering: PCSK9 inhibitors – new kids on the block target their breakthrough
by: Markus Mohaupt
Published: (2016-07-01)

Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale
by: Tamio Teramoto, et al.
Published: (2017-06-01)

A practical algorithm for the management of patients with statin-associated muscle symptoms
by: Loukianos S. Rallidis
Published: (2020-03-01)

The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial
by: Fiona J. Dore, et al.
Published: (2018-05-01)